ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Accepts sBLA for BOTOX for Neurogenic Detrusor Overactivity americanpharmaceuticalreview
July 02, 2020Allergan, an AbbVie company, announced the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental biologics license application (sBLA) to expand the BOTOX? prescribing information for the treatment of signs and ...
Pharma Sources Insight January 2025
